PSF
SGMO

Pacific Sun Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Pacific Sun Financial’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93K Buy
+24,000
New +$9.55K ﹤0.01% 201

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Pacific Sun Financial's SGMO Position: Q1 2026 in Review

Pacific Sun Financial opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026: 24,000 shares worth $5.93K. The stake represents ﹤0.01% of the portfolio and ranks #201 among its holdings.

112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Pacific Sun Financial held 24,000 shares of SANGAMO THERAPEUTICS INC worth $5.93K as of Q1 2026.
  • SANGAMO THERAPEUTICS INC was a new Pacific Sun Financial position in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Pacific Sun Financial's portfolio in Q1 2026, its #201 holding.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Pacific Sun Financial's 13F filing for Q1 2026, filed 8 May 2026.